TrademarkDir
OP2 DRUGS
LIVE

Serial Number

79234199

Owner

OP2 DRUGS

Attorney

Pina M. Campagna

Filing Date

Mar 13, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OP2 DRUGS Trademark

Serial Number: 79234199 • Registration: 5986647

OP2 DRUGS is a trademark filed by OP2 DRUGS on March 13, 2018. The trademark is classified under Class 1 (Chemicals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

OP2 DRUGS (2 trademarks)

PTIB Université de Bordeaux,
PESSAC CEDEX F-33604 , FR

Entity Type: 34

Trademark Details

Filing Date

March 13, 2018

Registration Date

February 18, 2020

Published for Opposition

February 19, 2019

Cancellation Date

September 4, 2026

Goods & Services

Medical apparatus and instruments for treating cardiovascular and neurological disease

chemicals for use in industry and science

Filing History

CANCELLED SECTION 71
Sep 4, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 18, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 12, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 21, 2020 FICS
FINAL DISPOSITION PROCESSED
May 21, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 18, 2020 FICR
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2020 NREP
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2020 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Jan 14, 2020 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 14, 2020 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 14, 2020 OP.D
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 6, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 20, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 20, 2019 OPNR
REFUSAL PROCESSED BY IB
Sep 13, 2019 RFNP
OPPOSITION INSTITUTED NO. 999999
Aug 27, 2019 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Aug 19, 2019 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Aug 17, 2019 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 12, 2019 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 19, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 16, 2019 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2019 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 30, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 30, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 30, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2019 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 8, 2019 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2019 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jan 4, 2019 NREP
REFUSAL PROCESSED BY IB
Jul 27, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 11, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jul 11, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 27, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jun 26, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 19, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 14, 2018 REPR

Related Trademarks

More from this Owner

OP2 INNOVATIVE DRUGS logo

OP2 INNOVATIVE DRUGS

OP2 INNOVATIVE DRUGS logo

OP2 INNOVATIVE DRUGS

OP2 INNOVATIVE DRUGS logo

OP2 INNOVATIVE DRUGS